Metabolic and Nutritional Responses to Acute High-intensity Interval Exercise Performed Under Hypoxic vs. Normoxic Conditions at Matched External Workload in Adults With Overweight and Obesity.
HYPOXHIIT
Comparison of HIIT Exercise Under Hypoxic and Normoxic Conditions in Adults With Overweight or Obesity: Impact on Oxygen Consumption, Carbohydrate and Lipid Substrate Utilization, and Appetite During Recovery.
1 other identifier
interventional
18
1 country
1
Brief Summary
Obesity management involves lifestyle and dietary measures that include appropriate nutrition and increased physical activity (PA). Among the various PA options available, HIIT (High-Intensity Interval Training) workouts are now recognized as fun and effective programs for promoting fat loss. To date, in overweight or obese individuals, only two studies mention the benefits of HIIT performed under hypoxia for modulating body composition, and more specifically, reducing the amount of adipose tissue. These studies hypothesize an increased energy expenditure under hypoxia associated with a transient loss of appetite. In order, to further investigate the adaptations following HIIT under hypoxia versus normoxia, we propose to compare, in acute conditions, two HIIT sessions (simulated hypoxia-normobaric vs. normoxia) in overweight or obese subjects. The objective of this assessment is to compare, during exercise and recovery (+2h), oxygen consumption, corresponding energy expenditure, and carbohydrate and lipid utilization in hypoxic versus normoxic conditions. Given the potential influence of hypoxia on appetite, spontaneous food intake and energy expenditure post-24h will also be measured. Finally, since pleasure and perceived exertion are key parameters in adherence to an adapted physical activity (APA) program, these two concepts will also be evaluated through the subjects' experiences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 5, 2026
CompletedFirst Posted
Study publicly available on registry
September 11, 2026
CompletedSeptember 11, 2026
September 1, 2026
1.8 years
September 5, 2026
September 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lipid oxidation after the exercise session (nromoxia and hypoxia).
Determination of lipid and carbohydrate oxidation after the exercise (HIIE normoxia and hypoxia). Lipid aoxidation is measured from oxygen and carbon dioxide consumption (Metamax 3D Cortex).
Measurement during two hours after the end of the exercise
Secondary Outcomes (3)
Oxygen consumption during the recovery period
Two hours after the end of the exercise
Energy intakes 24 hours after the exercise
24 hours post exercise
Appetite
Before exercise and after exercise (+0 min, +60 min, and +120 min).
Study Arms (2)
High Intensity Interval Exercise - Normoxia
EXPERIMENTALHIIE in normoxia
High Intensity Interval Exercise - Hypoxia
EXPERIMENTALHIIE in hypoxia
Interventions
Cycling HIIE in Normoxia: 60 x \[8 seconds at a power equivalent to 80-85% of HRmax followed by 12 seconds of active recovery at a power equivalent to 40% of HRmax\]
Cycling HIIE in Hypoxia (FiO2: 15%): 60 x \[8 seconds at a power equivalent to 80-85% of HRmax followed by 12 seconds of active recovery at a power equivalent to 40% of HRmax\]
Eligibility Criteria
You may qualify if:
- \- overweight or obesity (BMI between 25 kg/m2 and 35 kg/m2)
You may not qualify if:
- medical contraindications to intense physical activity
- taking ß-blocker
- diabete
- women taking hormonal replacement therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CREPS Auvergne Rhône-Alpes / Vichy
Bellerive-sur-Allier, Allier, 03321, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Data collected on the volunteers will be made anonymous.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2026
First Posted
September 11, 2026
Study Start
November 1, 2024
Primary Completion
September 1, 2026
Study Completion
September 1, 2026
Last Updated
September 11, 2026
Record last verified: 2026-09